European Stroke Organisation
With each passing year, European Stroke Organization (ESO) successfully moves ahead with its aim of being the European global point of reference and support for global stroke healthcare personnel. We will strive, as always, to gain and maintain the trust of our society members worldwide through a transparent administration, a timely and constant monitoring of pertinent objectives, and an open approach that greets the many vicissitudes of this stimulating field as welcomed opportunities.
At the ESO Conference 2016 in Barcelona, >3700 colleagues attended from 97 countries, >1400 abstracts were submitted, 3 NEJM publications were communicated for the first time during the large clinical trial session, and the first allied healthcare sessions were held. We extend our sincere thanks to the trialists who chose ESO Conference to present their ground-breaking results. Moreover, our gratitude goes to our sponsors who continue to deliver their support.
ESO Conference 2017 will be held in Prague, Czech Republic, on May 16 to 18, 2017. The new program committee, will be for the first time, composed of senior colleagues along with rising stars, to construct a scientific program that best reflects all ESO members on directions in research. Therefore, it has been decided to increase the time devoted to oral communications. The space allotted to allied health careers will be enlarged to numerous sessions throughout the conference. The aim is to fully recognize the contribution and value of allied health careers in stroke care and research. ESO will continue to rotate the conference venues with an eastern venue in Prague (2017) after the north-western venue in Glasgow (2015) and the southern venue in Barcelona (2016), returning to the northwest in Gothenburg (2018).
The ESO is pleased to announce that the first issue of its European Stroke Journal has been published this year. This event was made possible because of the personal commitment of our Past-President Kennedy Lees, along with the dedicated ESO journal committee members. Gratefully, Professor Bo Norrving and Didier Leys have accepted the challenge of leading the journal as its Editor-in-Chief and Vice Editor, respectively. The journal is wholly owned by ESO, and its editors have been granted full editorial independence. European Stroke Journal will provide a further voice for scientific contributions from all over the world, especially for the thriving stroke research community in Europe. In its first issue, the ESO guidelines for prophylaxis for venous thromboembolism in immobile patients with acute ischemic stroke were published, and other modules are planned. Current ESO guidelines can be downloaded on mobile devices through the ESO Pocket Guidelines App for use (http://www.eso-stroke.org/eso-stroke/education/eso-pocket-guidelines-app.html). The European Recommendations on Organization of Interventional Care in Acute Stroke endorsed by ESO, European Academy of Neurology (EAN), European Society of Minimally Invasive Neurological Therapy (ESMNIT), and European Society of Neuroradiology (ESNR) will shortly be published simultaneously in both International Journal of Stroke and European Stroke Journal.
Randomized controlled trials have consistently shown that endovascular stroke treatment combined with best medical treatment in stroke patients with large-vessel occlusion in the anterior circulation is superior to best medical treatment alone. However, it is known that disparities exist throughout Europe on access to this highly effective therapy.
ESO—together with ESMNIT, EAN, and Stroke Alliance for Europe (SAFE)—is therefore organizing a multicenter survey on endovascular stroke treatment practices in Europe to pinpoint where access to this highly effective therapy is lacking. To effectively carry out this survey, national stroke and neurological societies throughout Europe will be contacted by the ESO European Society of Minimally Invasive Neurological Therapy European Academy of Neurology SAFE task force with the aim of identifying all providers of acute stroke care. A structured questionnaire will be forwarded to all providers on their access to current endovascular facilities and their practices. On completion of this survey, any barriers to the uptake of endovascular stroke interventions will be presented to European officials with the aim of redesigning a more uniform access to current healthcare treatment and practices throughout Europe.
The ESO-EAST (Enhancing and Accelerating Stroke Treatment) project, with its focus of Enhancing and Accelerating Stroke Treatment in Eastern Europe, is now in its second year (http://www.eso-stroke.org/eso-stroke/esoeast/about-eso-east-project.html). Regional meetings have been held in Ukraine, Georgia, Poland, and Romania, whereas a Stroke Unit Nurse Education Meeting has been held in Kiev, Ukraine, this year. Furthermore, ESO together with the St. Anne’s University Hospital Brno is setting up a quality registry for stroke treatment in Eastern Europe. The developed web-based electronic registry can be visited at http://126.96.36.199:8080/OpenClinica/pages/login/login;jsessionid=A809CE2F656284A2A8DDAA2FF988954C.
Moreover, ESO is proud to introduce the ESO Stroke Unit and Stroke Center Certification Platform for European institutions. The aims of this certification project are to improve the quality of patient care by reducing variation in clinical processes and to provide a benchmark for quality of stroke management. In fact, ESO certification will provide an opportunity for the local staffs to develop their skills and knowledge. This will strengthen the community confidence in the quality and safety of care, treatment, and services. Stroke units will be evaluated by auditors and the ESO Stroke Unit Committee, and laboratories passing certification process will be included in a database and will be posted on the ESO website (http://www.eso-stroke.org/eso-stroke/esoactivities/eso-stroke-unit-and-stroke-center-certification.html).
ESO is continuing to collaborate with the European Society of Cardiology after endorsing the upcoming 2016 European Society of Cardiology Guidelines for the management of atrial fibrillation developed in collaboration with European Association of CardioThoracic Surgery (EACTS), and our guideline committee has contributed to the 2016 European Guidelines for Cardiovascular Disease Prevention in Clinical Practice.
There are many on-going educational activities: ESO Stroke Summer School 2016 will be held in Madrid, whereas in 2017, it is scheduled to take place in Larissa, Greece. The application deadline for the postgraduate Master Program in Stroke held at Danube University in Krems, Austria, is July 15, 2016. The next ESO-Karolinska Stroke Update Conference will take place on November 13 to 15, 2016, in Stockholm, Sweden, providing updates on recent stroke therapy research. It will be an opportunity for participants to debate ESO stroke guidelines and voice their input on future directions. The fourth ESO, ESMINT, ESNR Stroke Winter School is an acute interdisciplinary stroke treatment course for young stroke physicians and neuroradiologists, offers practical training in endovascular stroke treatment, and will be held in Bern, Switzerland, from January 31 to February 3, 2017.
All these membership activities give credence to ESO’s aim of being the European global point of reference and support for global stroke healthcare personnel. Details of ulterior ESO activities and opportunities can be found at http://www.eso-stroke.org/eso-stroke/home.html.
Dr Fischer is a consultant for Covidien. The other authors report no conflicts.
- © 2016 American Heart Association, Inc.